Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
Clinical trial NCT05782179 · COMPLETED
Trial details
- NCT number
- NCT05782179
- Sponsor
- Minervax ApS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-12-14
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.